Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
51.09
Price to sales ratio
2.96

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1106
PACS
PACS Group, Inc. Common Stock
44.98 USD+0.13%+0.74%+23.67%+250.18%7.12 B USD
1165
CHE
Chemed Corp
493.03 USD+0.31%+2.51%+13.16%+7.53%6.54 B USD
1478
LFST
LifeStance Health Group, Inc. - Common Stock
11.07 USD+2.59%+4.93%+28.42%+111.66%4.29 B USD
1522
CON
Concentra Group Holdings Parent, Inc. Common Stock
30.89 USD-0.06%-1.47%+9.00%+46.89%3.95 B USD

Frequently asked questions about Caris Life Sciences, Inc. - Common Stock

What is the Caris Life Sciences, Inc. - Common Stock stock price today?

The current price of Caris Life Sciences, Inc. - Common Stock (CAI) is 17.62. Over the past 24 hours, the stock has changed by +3.95%. Follow the CAI chart for real-time price dynamics.

What is the stock ticker of Caris Life Sciences, Inc. - Common Stock?

Caris Life Sciences, Inc. - Common Stock trades under the ticker CAI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Caris Life Sciences, Inc. - Common Stock stock going up?

CAI has changed by +4.94% over the last week, -3.19% over the last month, and -40.35% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Caris Life Sciences, Inc. - Common Stock release financial reports?

Yes. You can track Caris Life Sciences, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Caris Life Sciences, Inc. - Common Stock net income for the last quarter?

Caris Life Sciences, Inc. - Common Stock reported net income of -510 K for the last quarter. The previous quarter showed 81.96 M, which means net income changed by -100.62%.

How many employees does Caris Life Sciences, Inc. - Common Stock have?

As of the latest available data, Caris Life Sciences, Inc. - Common Stock has 1 846 employees. Workforce size can provide additional context about the company's scale and operations.

What is Caris Life Sciences, Inc. - Common Stock EBITDA?

Caris Life Sciences, Inc. - Common Stock EBITDA is 10.35 M, and its EBITDA margin is 4.79%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Caris Life Sciences, Inc. - Common Stock stock?

You can buy Caris Life Sciences, Inc. - Common Stock (CAI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Caris Life Sciences, Inc. - Common Stock stock?

Investing in Caris Life Sciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CAI chart and related analysis on metatrader.com as part of your research.